Global Opportunities Gp Llc Viking serves as Executive at BridgeBio Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Global Opportunities Gp Llc Viking has executed 6 insider transactions totaling $255.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 26, 2024 involved transacting 1,743,556 shares valued at $0.
Global Opportunities Gp Llc Viking currently holds 27,032,516 shares of BridgeBio Pharma, Inc. (BBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Global Opportunities Gp Llc Viking has been a net seller of BBIO stock. They have purchased $0 and sold $255.9M worth of shares.
Global Opportunities Gp Llc Viking's most recent insider trade was on Feb 26, 2024, when they sold 1,743,556 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 2, 2024 | APG | $197.2M | Sale | 6,300,817 | $31.30 | Discretionary |
| Jan 2, 2024 | APG | $6.1M | Sale | 195,200 | $31.30 | Discretionary |
| Jan 2, 2024 | APG | $124.7K | Sale | 3,983 | $31.30 | Discretionary |
| Jul 18, 2023 | BBIO | $52.5M | Sale | 1,500,000 | $35.00 | Discretionary |